So far, the penny stock of Biozoom, Inc. (BIZM) has been more of a putter than a zoomer, but you won’t hear too many traders complaining about that. As if it was targeting its 1st resistance point each and every trading session since it became active, BIZM stock seems to do only one thing: close green. With the last two trading sessions proving that accumulation is in full swing on makes of the Biozoom scanner, its not just Vegans who are taking a bite out of what could be the next $2 runner now that Lot78 Inc. (LOTE) has officially FS.
Our Next Pick Is Coming Soon! Click HERE To Make Sure You Don’t Miss Any Of Our Breaking Alerts!
BIZM Stock Quote
Market Cap: 95.57M
Tuesday Close: 1.60 ▲ 0.05 (+3.23%)
Volume: 1,285,500
Open: 1.56
High: 1.60
Low: 1.5366
1st Resistance Point: 1.6211
2nd Resistance Point: 1.6423
1st Support Level: 1.5577
Looking for Hot Penny Stocks?
Click here To Receive FREE Penny Stock Alerts
On Friday, Biozoom filed an 8-K updating some details about a letter received back on or about February 25, 2013 which was addressed to Dr. Wolfgang Köcher, CTO and director of Biozoom, Inc. Those who took the time to go through the attachments from the Charité – Universitätsmedizin Berlin, Center of Experimental and Applied Cutaneous Physiology, regarding the efficacy, past use by the Charité, and potential use of the registrant’s handheld mobile spectroscopic scanner technology solidified their decision to have gotten into BIZM stock when we first covered it at $1.44.
The PR attached clearly had the “MEAT” in mind when it was released as it stated: According to the respected management consulting firm, McKinsey, the global health and wellness market will reach $1 trillion before the decade is out, and Biozoom (BIZM) is poised to be a major force in that growth.
After test were conducted by released by the Charité – Universitätsmedizin Berlin on volunteers aged between 40-50, investigating their skin surface structure and their antioxidant concentration levels, the conclusion came back that using the Biozoom scanner would likely help these persons keep their antioxidant levels high, preventing premature skin-aging and keeping them looking young and healthy.
Using advanced optics produced by Carl Zeiss, the Biozoom scanner is a breakthrough in anywhere, anytime wellness management. On that note, BIZM should continue to be a gem of a penny stock this summer with aspirations of being 10X better than your average, “run of the mill” OTC promotion.
About BIZM Stock
Biozoom, Inc. is a development stage company that holds certain patents and licenses to technology in the field of devices that use spectroscopics to detect and measure substances within the body or other biological substances.
Click here to view the SEC filings for BIZM.
Click here to view the website for Biozoom.
Last 5 Trading Sessions:
| Date | Last | Change | % Change | Volume |
| 06/04/13 | 1.6000 | +0.0500 | +3.23% | 1,285,500 |
| 06/03/13 | 1.5500 | +0.0700 | +4.73% | 2,105,200 |
| 05/31/13 | 1.4800 | +0.0200 | +1.37% | 336,700 |
| 05/30/13 | 1.4600 | +0.0300 | +2.10% | 537,500 |
| 05/29/13 | 1.4300 | +0.0300 | +2.14% | 349,100 |
Stay Connected With Us:
Bottom Line:
Unless you’re a cheapy who loves to play in the sub-pennies, there is little not to like about BIZM as your top penny stock for June. Sure you can make bigger gains on cheaper stocks, but the volume is picking up on BIZM stock which means that those willing to “go big or go home” are putting themselves in a position to make $10,924, $20,897, maybe even $400,656?
Here is your opportunity to subscribe to the Most Read Penny Stock Newsletter
If You Can’t Make Money With Us, You Shouldn’t Be Trading Penny Stocks
(We are 100% Anti-Spam and will never rent or sell your information)
ShareJUN
